Skip to main content

SkinBioTherapeutics shortlisted for Biotech and Money 2017 Awards

SkinBioTherapeutics shortlisted for Biotech and Money 2017 Awards

SkinBioTherapeutics plc a life science company focused on skin health, has been nominated as a finalist in the Life Science IPO of the Year category of the Biotech and Money 2017 Awards.

The 2017 Biotech and Money Assembly and Awards Gala Dinner celebrates the UK’s funding, finance and investment success in the life sciences sector over the past 12 months.

SkinBioTherapeutics has been nominated for its IPO in April 2017 which raised £4.5 million in funds to enable the development of its proprietary SkinBiotix® technology platform and to accelerate the clinical development of its main therapeutic candidates. Their aim is to target cosmetic products, infection control and dermatological conditions.

Contact Us

Online form

If you would like to speak to us about an investment opportunity or would like some information on how to invest with Seneca, please contact us and a member of the team will be pleased to help you.
  • Would you like to receive Seneca Partners Newsletter updates?

  • Would you like to receive Seneca Partners Onside Magazine?

  • Would you like to receive Seneca Partners Event Updates?

  • Before submitting this form, please confirm that you have read and agree with our website Terms & Conditions

  • This field is for validation purposes and should be left unchanged.
Visit Seneca Partners Website